Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

NCT05319015 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Neoadjuvant Lenvatinib
DRUG: Neoadjuvant Pembrolizumab
PROCEDURE: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection
DRUG: Adjuvant Pembrolizumab

Sponsor

University of Texas Southwestern Medical Center